[HTML][HTML] Profile of People Living with Human Immunodeficiency Virus Initiating Treatment in the Dolutegravir Era in Kinshasa, Democratic Republic of Congo

BI Bongenya, BO Kabengele, MTAS Sombo… - World Journal of …, 2023 - scirp.org
Background: For several decades, the introduction of AntiRetrovirals (ARVs) has improved
the symptomatology of People Living with HIV (PLHIV), a spectacular reduction in morbidity …

Clinical Profile of People Living with Human Immunodeficiency Virus Starting Treatment in Kinshasa, Democratic Republic of Congo

GI Booto, SM Selenge, BI Bongenya… - Open Access Library …, 2022 - scirp.org
Context: For several decades, the introduction of AntiRetroViral (ARV) has allowed an
improvement in the clinical signs of patients, a spectacular reduction in mortality and …

[HTML][HTML] Virological and Molecular Profile of People Living with the Human Immunodeficiency Virus Starting Dolutegravir Based Antiretroviral Treatment in Kinshasa …

BI Bongenya, CL Tshinguta, MTAS Sombo… - World Journal of …, 2023 - scirp.org
Context: Despite the new recommendations “Test and Treat”, the virological and molecular
parameters remain important information for Antiretroviral Treatment and adequate for …

Biological Profile of People Living with Human Immunodeficiency Virus Starting Treatment in Kinshasa, Democratic Republic of the Congo

BI Bongenya, MTAS Sombo, GMM Bumoko… - World Journal of …, 2023 - scirp.org
Context: The biochemical assessment is a real-time indicator of the state and evolution of an
infection. Among other things, it makes it possible to determine the right moment when it …

Compliance with First-Line AntiRetroViral Treatment (ART) for HIV Infection in the Era of Dolutegravir in Kinshasa, Democratic Republic of the Congo

BI Bongenya, MTAS Sombo, GMM Bumoko… - World Journal of …, 2023 - scirp.org
Context: Two years after the transition to Dolutegravir (DTG), at the national level, data on
compliance with the execution of this transition and the rational use of the new molecule are …

Virological and Molecular Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa

BI Bongenya, C Tshinguta, BO Kabengele… - World Journal of …, 2023 - scirp.org
Context: The appointment of the M6 is crucial because it is an indicator of the prognosis of
the evolution of the care and the decision-making on the continuation of the AntiRetroViral …

Prevalence of Anemia among People Living with HIV/AIDS Starting Antiretroviral Therapy in the Era of Dolutegravir in Kinshasa, Democratic Republic of Congo

BB Ikolango, M Lusakibanza, GM Kahunu… - Open Access Library …, 2023 - scirp.org
Background: Anemia remains the most frequent hematological complication during
HIV/AIDS infection. Objective: The objective of this study was to determine the prevalence of …

[PDF][PDF] Opportunistic Infections in People Living with Human Immunodeficiency Virus Initiating Antiretroviral Therapy in Kinshasa, Democratic Republic of Congo

TN Kaseka, BB Ikolango, LL Omombo, GB Ipaya… - Austin J Infect …, 2022 - researchgate.net
Background: Opportunistic infections, which are still a major problem in the care of People
Living with HIV (PLHIV), occur in situations of immunosuppression. Objective: The objective …

Virological Profile of People Living with HIV after 12 Months of Treatment with Dolutegravir in Kinshasa

BI Bongenya, MTAS Sombo, GMM Bumoko… - World Journal of …, 2023 - scirp.org
Context: The evaluation of plasma Viral Load constitutes an indicator of the progression of
the infection, the effectiveness and the tolerance of the treatment. Objective: The objective of …

Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa

BI Bongenya, BO Kabengele, MTAS Sombo… - Advances in Infectious …, 2023 - scirp.org
Introduction: The sixth month appointment (M6) is crucial because at the start of the ART
course, it is an indicator of the prognosis of the evolution of care and decision-making on the …